Court of Appeals rules in favor of Mylan in Oxybutynin patent case (News-Medical-Net)
Court of Appeals rules in favor of Mylan in Oxybutynin patent case (News-Medical-Net)
Mylan Laboratories Inc. has announced that the U.S. Court of Appeals for the Federal Circuit upheld a district court decision that Mylan’s Oxybutynin products do not infringe a patent for DITROPAN XL and that the patent was invalid.